Difficult Cannulation Criteria in Trainee Involved ERCP Cannulation

Sponsor
Air Force Military Medical University, China (Other)
Overall Status
Completed
CT.gov ID
NCT04609917
Collaborator
(none)
4,415
1
7.7
576.7

Study Details

Study Description

Brief Summary

Endoscopic Retrograde Cholangiopancreatography (ERCP) is one of the most technically challenging procedures in gastrointestinal endoscopy. Selective deep cannulation is a critical step for the performance of ERCP. The incidence of difficult cannulation has been reported in many studies, ranging from 10% to 40% in patients with native papilla. Difficult cannulation is an independent risk factor for post-ERCP pancreatitis (PEP).

The definition of difficult cannulation has been proposed by European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Initial cannulation is considered difficult with the presence of one or more of the following: more than 5 min for attempting to cannulate; more than 5 contacts with the papilla; more than 1 unintended pancreatic duct cannulation or opacification. The clear definition of difficult cannulation is important for making decisions during or after ERCP, including determining the appropriate time to transfer to advanced cannulation techniques (e.g. early precut) and whether prophylactic methods should be administrated to reduce the risk of PEP. Although 5-5-1 criteria have been widely used during ERCP practice or in relevant studies, it remains unclear whether the current criteria are suitable for the cannulation procedure with trainee involvement. Because of inexperienced manipulation of the scope and accessories, the involvement of trainees generally increases the overall cannulation time and attempts, which are the two important parameters in the criteria of difficult cannulation. Thus, the investigators hypothesized that the definition of difficult cannulation in trainee-involved cannulation might be different from the traditional 5-5-1 criteria.

Condition or Disease Intervention/Treatment Phase
  • Procedure: trainee invlovement

Study Design

Study Type:
Observational
Actual Enrollment :
4415 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Proposal of Difficult Cannulation Criteria in Trainee Involved ERCP Cannulation Procedure
Actual Study Start Date :
Mar 1, 2020
Actual Primary Completion Date :
Oct 1, 2020
Actual Study Completion Date :
Oct 20, 2020

Arms and Interventions

Arm Intervention/Treatment
trainee group

Patients with native papilla who underwent selective biliary cannulation with trainee involvement

Procedure: trainee invlovement
Patients underwent selective biliary cannulation with trainee involvement

non-trainee group

Patients with native papilla who underwent selective biliary cannulation without trainee involvement

Outcome Measures

Primary Outcome Measures

  1. rates of difficult cannulation [2 hours]

    The proportion of the participants with cannulation-related parameters (cannulation time, cannulation attempts, or inadvertent PD cannulation) above the 75% percentile

Secondary Outcome Measures

  1. incidences of PEP [48 hours]

  2. overall adverse events [48 hours]

  3. the proportion of advanced cannulation methods [4 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with native papilla
Exclusion Criteria:
  • indications of major or minor pancreatic duct (PD) cannulation; no attempts of cannulation due to inaccessible papilla; cannulation via the papillary fistula; patients with duodenal stenosis or anatomical deformity secondary to prior surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Endoscopic center, Xijing Hospital of Digestive Diseases Xi'an Shaanxi China 710032

Sponsors and Collaborators

  • Air Force Military Medical University, China

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yanglin Pan, Associate Professor, Air Force Military Medical University, China
ClinicalTrials.gov Identifier:
NCT04609917
Other Study ID Numbers:
  • KY20201021-2
First Posted:
Oct 30, 2020
Last Update Posted:
Oct 30, 2020
Last Verified:
Oct 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yanglin Pan, Associate Professor, Air Force Military Medical University, China

Study Results

No Results Posted as of Oct 30, 2020